Evidence map›Paper›PMID 35408876›Full record

ArticleInternational journal of molecular sciences2022

Resemblance-Ranking Peptide Library to Screen for Binders to Antibodies on a Peptidomic Scale.

Felix Jenne, Sergey Biniaminov, Nathalie Biniaminov, Philipp Marquardt, Clemens von Bojničić-Kninski, Roman Popov, Anja Seckinger, Dirk Hose, Alexander Nesterov-Mueller

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.9field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Felix JenneInstitute of Microstructure Technology, Karlsruhe Institute of Technology (KIT), 76344 Eggenstein-Leopoldshafen, Germany.
Sergey BiniaminovHS Analysis, Haid-und-Neu-Straße 7, 76131 Karlsruhe, Germany.ORCID 0000-0002-4876-1883
Nathalie BiniaminovHS Analysis, Haid-und-Neu-Straße 7, 76131 Karlsruhe, Germany.
Philipp MarquardtHS Analysis, Haid-und-Neu-Straße 7, 76131 Karlsruhe, Germany.
Clemens von Bojničić-KninskiAxxelera, Karl-Floesser-Str. 14, 76189 Karlsruhe, Germany.
Roman PopovAxxelera, Karl-Floesser-Str. 14, 76189 Karlsruhe, Germany.
Anja SeckingerDepartment of Hematology and Immunology, Myeloma Center Brussels, Vrije Universiteit Brussel (VUB), Laarbeeklaan 103, 1090 Jette, Belgium.ORCID 0000-0002-2771-712X
Dirk HoseDepartment of Hematology and Immunology, Myeloma Center Brussels, Vrije Universiteit Brussel (VUB), Laarbeeklaan 103, 1090 Jette, Belgium.
Alexander Nesterov-MuellerInstitute of Microstructure Technology, Karlsruhe Institute of Technology (KIT), 76344 Eggenstein-Leopoldshafen, Germany.
Karlsruhe Institute of Technology · DEVrije Universiteit Brussel · BE

Funding

Deutsche Forschungsgemeinschaft AOBJ655892
6 · The paper itself

Abstract

A novel resemblance-ranking peptide library with 160,000 10-meric peptides was designed to search for selective binders to antibodies. The resemblance-ranking principle enabled the selection of sequences that are most similar to the human peptidome. The library was synthesized with ultra-high-density peptide arrays. As proof of principle, screens for selective binders were performed for the therapeutic anti-CD20 antibody rituximab. Several features in the amino acid composition of antibody-binding peptides were identified. The selective affinity of rituximab increased with an increase in the number of hydrophobic amino acids in a peptide, mainly tryptophan and phenylalanine, while a total charge of the peptide remained relatively small. Peptides with a higher affinity exhibited a lower sum helix propensity. For the 30 strongest peptide binders, a substitutional analysis was performed to determine dissociation constants and the invariant amino acids for binding to rituximab. The strongest selective peptides had a dissociation constant in the hundreds of the nano-molar range. The substitutional analysis revealed a specific hydrophobic epitope for rituximab. To show that conformational binders can, in principle, be detected in array format, cyclic peptide substitutions that are similar to the target of rituximab were investigated. Since the specific binders selected via the resemblance-ranking peptide library were based on the hydrophobic interactions that are widespread in the world of biomolecules, the library can be used to screen for potential linear epitopes that may provide information about the cross-reactivity of antibodies.

Indexed as

AntibodiesPeptide LibraryAmino AcidsEpitopesHumansPeptidesRituximabAmino AcidsAntibodiesEpitopesPeptide LibraryPeptidesRituximaboff targetingrituximabultra-high-density peptide microarrays

Identifiers

PMID35408876
PMCPMC8999133
OpenAlexW4220740099

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.